The Hyderabad based Dr Reddy’s Lab, the country’s third-biggest drug maker, will form a joint venture with one of the world’s biggest biotech companies to make biosimilars or generic versions of patented biotech drugs to take on Ranbaxy Laboratories, Reliance Life Sciences, among other Indian companies. Several drugs are expected to come off patent in this segment in the next five years. Link (Source: buisness standard)
Tuesday, 29 July 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment